Patients were excluded if, in the baseline period, weight 181 kg, latest BMI 30 kg/m 2 [31]
Future RCTs should test various GLP-1RAs across broader AUD populations, standardize outcomes, and explore body weights moderating role
Furthermore, exenatide has been demonstrated to mitigate mitochondrial oxidative stress, reduce Ca 2 overload, inhibit fission, and close the mitochondrial permeability transition pore (mPTP), collectively preventing cardiomyocyte apoptosis by inhibiting the release of proapoptotic proteins such as cytochrome c and caspase-3 [94]
I also didnt notice melasma building on my face
Eligibility depends on factors such as: Current Wegovy dose and duration of use Weight-loss progress and overall health outcomes History of side effects or intolerance Other medical conditions (such as pancreatitis or gallbladder disease) Other medications being taken Switching should only be considered after a structured review with a doctor who understands your full medical history and treatment goals